Phase 1 Study of Decitabine and Vorinostat Followed By Fludarabine, Cytarabine and G-CSF (FLAG) in Children, Adolescents and Young Adults with Relapsed/Refractory AML: Report from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium

被引：1
|
作者：
Pommert, Lauren [1 ,2 ]
Bhojwani, Deepa
Sposto, Richard [3 ,4 ]
Florendo, Ellynore [5 ]
Schafer, Eric [6 ]
Gossai, Nathan [7 ]
Van Thu Huynh [8 ]
Rao, Sridhar [9 ]
Burke, Michael J. [10 ]
机构：
[1] Childrens Hosp Wisconsin, Dept Pediat, Milwaukee, WI 53201 USA
[2] St Jude Childrens Res Hosp, Div Hematol Oncol Blood & Marrow Transplantat, Los Angeles, CA USA
[3] Univ Southern Calif, Los Angeles, CA 90007 USA
[4] Childrens Hosp Angeles, Pediat, Los Angeles, CA USA
[5] Childrens Ctr Canc & Blood Dis, Dept Pediat, Los Angeles, CA USA
[6] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[7] Childrens Hosp Minnesota, Dept Pediat, Minneapolis, MN USA
[8] CHOC Childrens Hosp, Orange, CA USA
[9] Versiti, Blood Res Inst, Milwaukee, WI USA
[10] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-127298
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 22 条
  • [1] Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium
    Pommert, Lauren
    Schafer, Eric S.
    Malvar, Jemily
    Gossai, Nathan
    Florendo, Ellynore
    Pulakanti, Kirthi
    Heimbruch, Katelyn
    Stelloh, Cary
    Chi, Yueh-Yun
    Sposto, Richard
    Rao, Sridhar
    Huynh, Van Thu
    Brown, Patrick
    Chang, Bill H.
    Colace, Susan, I
    Hermiston, Michelle L.
    Heym, Kenneth
    Hutchinson, Raymond J.
    Kaplan, Joel A.
    Mody, Rajen
    O'Brien, Tracey A.
    Place, Andrew E.
    Shaw, Peter H.
    Ziegler, David S.
    Wayne, Alan
    Bhojwani, Deepa
    Burke, Michael J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (05) : 613 - 622
  • [2] Pilot Study of Decitabine and Vorinostat with Chemotherapy for Relapsed ALL: A Report from the Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Consortium
    Burke, Michael J.
    Brown, Patrick
    Sposto, Richard
    Gore, Lia
    Wayne, Alan S.
    BLOOD, 2016, 128 (22)
  • [3] Results from the Phase 1 Portion of a Trial of Oral Ixazomib Combined with Chemotherapy in Relapsed/Refractory Acute Lymphoblastic Leukemia or Lymphoma in Children, Adolescents and Young Adults: A Report from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium
    Schafer, Eric S.
    Chi, Yueh-Yun
    Malvar, Jemily
    Rushing, Teresa
    Doan, Andrew
    Pacenta, Holly L.
    Schore, Reuven J.
    Sposto, Richard
    Leong, Roy
    Gaynon, Paul S.
    Rubnitz, Jeffrey E.
    Barredo, Julio C.
    Slone, Tamra
    Pauly, Melinda
    Wayne, Alan S.
    Bhojwani, Deepa
    Horton, Terzah M.
    BLOOD, 2023, 142
  • [4] A Phase 1 Study of Azacitidine (AZA) in Combination with Fludarabine and Cytarabine in Relapse/Refractory Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study
    Sun, Weili
    Gaynon, Paul S.
    Sposto, Richard
    Bittencourt, Henrique
    Place, Andrew E.
    Messinger, Yoav H.
    Fraser, Chris
    Dalla-Pozza, Luciano
    van der Giessen, Jeannette
    Eckroth, Elena
    Yang, Xiaojing
    Liang, Gangning
    Jones, Peter A.
    Wayne, Alan S.
    Cooper, Todd
    BLOOD, 2014, 124 (21)
  • [5] Invasive Candida Infections in Pediatric Patients Treated on the Pilot Study of Decitabine and Vorinostat with Chemotherapy for Relapsed ALL: A Report from the Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Consortium
    Burke, Michael J.
    Brown, Patrick
    Gore, Lia
    Sposto, Richard
    Bhojwani, Deepa
    Chang, Bill H.
    Dubois, Steven G.
    Gaynon, Paul S.
    Glade-Bender, Julia
    Heym, Kenneth Matthew
    Sulis, Maria Luisa
    Pollard, Jessica A.
    Verma, Anupam
    Van Huynh
    BLOOD, 2014, 124 (21)
  • [6] A Phase I Study of AC220 in Combination with Cytarabine and Etoposide in Relapsed/Refractory Childhood ALL and AML: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study
    Cooper, Todd
    Sposto, Richard
    Cassar, Jeannette
    Eckroth, Elena
    Malvar, Jemily
    Gaynon, Paul
    Dubois, Steven
    Chang, Bill H.
    Gore, Lia
    August, Keith J.
    Thomson, Blythe
    Gammon, Guy
    Magoon, Daniel
    Annesley, Colleen E.
    Brown, Patrick
    BLOOD, 2012, 120 (21)
  • [7] A Phase I Study Of AC220 (Quizartinib) In Combination With Cytarabine and Etoposide In Relapsed/Refractory Childhood ALL and AML: A Therapeutic Advances In Childhood Leukemia & Lymphoma (TACL) Study
    Cooper, Todd Michael
    Malvar, Jemily
    Cassar, Jeannette
    Eckroth, Elena
    Sposto, Richard
    Gaynon, Paul
    Dubois, Steven
    Gore, Lia
    Macy, Margaret E.
    August, Keith J.
    Thomson, Blythe
    Oesterheld, Javier
    Gammon, Guy
    Magoon, Daniel
    Annesley, Colleen E.
    Brown, Patrick
    BLOOD, 2013, 122 (21)
  • [8] AAML 1421, a phase I/II study of CPX-351 followed by fludarabine, cytarabine, and G-CSF (FLAG) for children with relapsed acute myeloid leukemia (AML): A Report from the Children's Oncology Group.
    Cooper, Todd Michael
    Absalon, Michael
    Alonzo, Todd Allen
    Gerbing, Robert B.
    Leger, Kasey Joanne
    Hirsch, Betsy A.
    Pollard, Jessica Anne
    Razzouk, Bassem I.
    Aplenc, Richard
    Kolb, E. Anders
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] Phase I Study of Bortezomib Combined With Chemotherapy in Children With Relapsed Childhood Acute Lymphoblastic Leukemia (ALL): A Report From the Therapeutic Advances in Childhood Leukemia (TACL) Consortium
    Messinger, Yoav
    Gaynon, Paul
    Raetz, Elizabeth
    Hutchinson, Raymond
    DuBois, Steven
    Glade-Bender, Julia
    Sposto, Richard
    van der Giessen, Jeannette
    Eckroth, Elena
    Bostrom, Bruce C.
    PEDIATRIC BLOOD & CANCER, 2010, 55 (02) : 254 - 259
  • [10] Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium
    Verma, Anupam
    Chi, Yueh-Yun
    Malvar, Jemily
    Lamble, Adam
    Chaudhury, Sonali
    Agarwal, Archana
    Li, Hong-Tao
    Liang, Gangning
    Leong, Roy
    Brown, Patrick A.
    Kaplan, Joel
    Schafer, Eric S.
    Slone, Tamra
    Pauly, Melinda
    Chang, Bill H.
    Stieglitz, Elliot
    Wayne, Alan S.
    Hijiya, Nobuko
    Bhojwani, Deepa
    CANCERS, 2024, 16 (03)
123